NUWIQ
STN: BL 125555
Proper Name: Antihemophilic Factor (Recombinant)
Tradename: NUWIQ
Manufacturer: Octapharma USA, Inc.
Indication:
- Indicated in adults and children with Hemophilia A for:
- On-demand treatment and control of bleeding episodes
- Perioperative management of bleeding
- Routine prophylaxis to reduce the frequency of bleeding episodes
Product Information
Supporting Documents
- Clinical Review - NUWIQ
- Statistical Review - NUWIQ
- Supporting Documents older than three years - NUWIQ
- Approval History, Letters, Reviews, and Related Documents - NUWIQ